Evidence map›Paper›PMID 41751921›Full record

ArticleInternational journal of molecular sciences2026

Novel Pyridine-Based Thiazolyl-Hydrazone as a Promising Attenuator of

Anabela Borges, Sanja Kokanov, Miguel M Leitão, Predrag Ristić, Irena Novaković, Vladimir Dobričić, Milan Nikolić, Mire Zloh, Tamara R Todorović, Manuel Simões and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anabela BorgesLEPABE (Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering), ALiCE (Associate Laboratory for Innovation in Chemical Engineering), Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal.ORCID 0000-0001-6929-6805
Sanja KokanovFaculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia.ORCID 0000-0001-6817-7409
Miguel M LeitãoLEPABE (Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering), ALiCE (Associate Laboratory for Innovation in Chemical Engineering), Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal.
Predrag RistićFaculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia.ORCID 0000-0002-7489-6132
Irena NovakovićInstitute of Chemistry, Technology and Metallurgy, University of Belgrade, Njegoševa 12, 11000 Belgrade, Serbia.
Vladimir DobričićDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia.ORCID 0000-0002-5086-9017
Milan NikolićFaculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia.ORCID 0000-0003-0932-889X
Mire ZlohUCL School of Pharmacy, University College London, 29/39 Brunswick Square, London WC1N 1AX, UK.ORCID 0000-0002-4848-2737
Tamara R TodorovićFaculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia.ORCID 0000-0002-7740-3639
Manuel SimõesLEPABE (Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering), ALiCE (Associate Laboratory for Innovation in Chemical Engineering), Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal.ORCID 0000-0002-3355-4398
Nenad R FilipovićFaculty of Agriculture, University of Belgrade, Nemanjina 6, 11000 Belgrade, Serbia.

Funding

This work was supported by: Project MultAntiBiofilm (ref. COMPETE2030-FEDER-00852000; Nº 17121); and HCAI_Disinfect (ref. COMPETE2030-FEDER-00752300; Nº 16360), funded through the Operational Programme Competitiveness Factors-COMPETE, and national funds b This work was supported by: Project MultAntiBiofilm (ref. COMPETE2030-FEDER-00852000; Nº 17121); and HCAI_Disinfect (ref. COMPETE2030-FEDER-00752300; Nº 16360), funded through the Operational Programme Competitiveness Factors-COMPETE, and national funds b
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsHydrazonesPseudomonas aeruginosaPyridinesQuorum SensingThiazolesAntioxidantsBacterial ProteinsBiofilmsMicrobial Sensitivity TestsMolecular Docking SimulationAnti-Bacterial AgentsAntioxidantsBacterial ProteinsHydrazonespyridinePyridinesThiazolesantibacterial resistancebiofilm preventiondockingmolecular dynamicsPseudomonas aeruginosaquorum-sensing inhibition

Identifiers

PMID41751921
PMCPMC12940498

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.